Miwei Biotech: Chairman and General Manager Liu Datao was fined 600,000 yuan for suspected short-term trading.

Maiwei Bio announced that its Chairman and General Manager, Liu Datao, has received an "Administrative Penalty Decision" from the Shanghai Regulatory Bureau of the China Securities Regulatory Commission for suspected insider trading. According to the content of the "Administrative Penalty Decision", Liu Datao, between January 18, 2022 and July 18, 2022, used Zhou's securities account to accumulate 976,600 shares of "Maiwei Bio", with a total transaction value of RMB 19.2977 million, and sold 634,300 shares of "Maiwei Bio", with a total transaction value of RMB 13.8836 million. In accordance with Article 44 and Article 189 of the Securities Law, Liu Datao has been given a warning and fined RMB 600,000. The above decision will not have a significant impact on the company's daily operations.